TMC125-TIDP2-C188: A PHASE I, OPEN-LABEL TRIAL TO INVESTIGATE THE PHARMACOKINETIC EFFECT OF MULTIPLE-DOSE TMC125 ON BUPRENORPHINE AND NORBUPRENORPHINE ADMINISTERED IN HIV-NEGATIVE PATIENTS ON STABLE BUPRENORPHINE/NALOXONE MAINTENANCE THERAPY.: